SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shinichi Nagase, Michiyo Ohyama, Yoshitaka Hashimoto, Maria Small, John Sharpe, Junichiro Manako, Tomohiro Kuwayama, Steve Deacon, Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women, Journal of Bone and Mineral Metabolism, 2014,

    CrossRef

  2. 2
    Klaus Jung, Michael Lein, Bone turnover markers in serum and urine as diagnostic, prognostic and monitoring biomarkers of bone metastasis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014, 1846, 2, 425

    CrossRef

  3. 3
    Elodie Feurer, Roland Chapurlat, Emerging drugs for osteoporosis, Expert Opinion on Emerging Drugs, 2014, 19, 3, 385

    CrossRef

  4. 4
    Serge Ferrari, Future directions for new medical entities in osteoporosis, Best Practice & Research Clinical Endocrinology & Metabolism, 2014, 28, 6, 859

    CrossRef

  5. 5
    Glen M. Blake, Musib Siddique, Michelle L. Frost, Amelia E. B. Moore, Ignac Fogelman, Imaging of Site Specific Bone Turnover in Osteoporosis Using Positron Emission Tomography, Current Osteoporosis Reports, 2014, 12, 4, 475

    CrossRef

  6. 6
    Heiani Touaitahuata, Anne Blangy, Virginie Vives, Modulation of osteoclast differentiation and bone resorption by Rho GTPases, Small GTPases, 2014, 5, 1, e28119

    CrossRef

  7. 7
    Natasha M. Appelman-Dijkstra, Socrates E. Papapoulos, Novel approaches to the treatment of osteoporosis, Best Practice & Research Clinical Endocrinology & Metabolism, 2014, 28, 6, 843

    CrossRef